US › Healthcare

Phaos Technology Holdings (Cayman) Limited (POAS)

US · Healthcare · Medical Devices

$0.73-1.35%

Last close · 2026-11-06

Latest quarter · ended 2026-07-31

Revenue

$36,303

Net profit

$-3.7M

Net margin

-10,114.8%

Key statistics

Market cap

$1.4M

Forward P/E

0.0

P/B

0.33

Book value

$1.97

EPS (TTM)

$-5.72

52-week high

$110.92

52-week low

$1.07

50-day MA

$2.31

200-day MA

$18.67

Shareholding

Insiders

29.98%

Institutions

4.46%

Corporate actions

Action	Detail	Date
Split	1 : 15 effective Oct 12, 2026	2026-10-12

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Phaos Technology Holdings (Cayman) Limited — free to start.

Open in the app Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc Merck & Company Inc UnitedHealth Group Incorporated Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Amgen Inc Gilead Sciences Inc Abbott Laboratories Novo Nordisk A/S

Data updated 2026-11-07.